This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bjps.2011.03.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Temporarily withdrawn: Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.
J Antimicrob Chemother
November 2024
Diagnostic Centre, Infectious and Tropical Diseases, Paris, France.
Improving Cardiac Rehabilitation Adherence in Patients With Lower Socioeconomic Status: A Randomized Clinical Trial.
JAMA Intern Med
September 2024
Department of Medicine, Division of Cardiology, University of Vermont, Burlington.
Importance: Participation in cardiac rehabilitation is associated with significant decreases in morbidity and mortality. Despite the proven benefits, cardiac rehabilitation is severely underutilized in certain populations, specifically those with lower socioeconomic status (SES).
Objective: To assess the efficacy of early case management and/or financial incentives for increasing cardiac rehabilitation adherence among patients with lower SES.
Mistaken information can lead only to misguided conclusions and policies: a commentary regarding Schüz et al.'s response.
Environ Health
September 2023
Okayama University of Science, Okayama, Japan.
Background: After reviewing selected scientific evidence, Schüz et al. made two recommendations in the 2018 International Agency for Research on Cancer (IARC) Technical Publication No. 46.
View Article and Find Full Text PDFHistiocytic neoplasms: Going, going, but not quite gone.
Br J Haematol
November 2023
Institute of Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UK.
BRAF and MEK inhibitors have revolutionised the treatment of patients with high-risk histiocytic neoplasms but does a complete response mean that treatment can be withdrawn? Commentary on: Reiner et al. Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms. Br J Haematol 2023;203:389-394.
View Article and Find Full Text PDFA systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [I]I-FP-CIT SPECT in routine practice.
Eur J Nucl Med Mol Imaging
June 2023
Amsterdam UMC location University of Amsterdam, Radiology and Nuclear Medicine, Meibergdreef 9, Amsterdam, The Netherlands.
Article Synopsis
- The text discusses the role of dopamine transporter (DAT) imaging as a diagnostic tool for Parkinson's disease and dementia, highlighting the importance of understanding how certain medications and drugs of abuse can affect imaging results.
- An update to a previous review from 2008 was conducted through a systematic literature search, which identified 44 relevant clinical studies from 838 publications, uncovering new insights on various substances' impact on DAT binding.
- The conclusion emphasizes that withdrawing certain drugs before DAT imaging can minimize false-positive results, but such decisions should be made carefully by healthcare specialists based on individual patient circumstances.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!